# Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

> **NCT01051219** · PHASE3 · COMPLETED · sponsor: **Newcastle-upon-Tyne Hospitals NHS Trust** · enrollment: 45 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT01051219
- **Lead sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2015-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01051219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01051219, "Anti-Fibrotic Effects of Losartan In Nash Evaluation Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01051219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*